TYRUKO JCV Antibody Test
Test Mnemonic
TJCVAB
Aliases
- JCV Antibody
- natalizumab
- Sandoz
Includes
- Anti-JCV Ab Index
Performing Laboratory
LabCorp
Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 1 mL | Serum | SST (Gold) | Ambient | Serum should be separated from cells within 45 minutes of collection. |
Alternate Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 1 mL | Serum | No additive (Red) | Ambient | Serum should be separated from cells within 45 minutes of collection. |
Minimum Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 0.5 mL | This volume does NOT allow for repeat testing. |
Stability
| Environmental Condition | Description |
|---|---|
| Frozen | 14 days |
| Refrigerated | 14 days |
| Ambient | 14 days |
Days Performed
Tue, Fri
Turnaround Time
8 - 11 days
Methodology
| Name | Description |
|---|---|
| Enzyme-Linked Immunosorbent Assay (ELISA) |
Reference Range
| Anti-JCV Ab Index | |||||
|---|---|---|---|---|---|
| Sex | Age From | Age To | Type | Range | Range Unit |
| Refer to report |
Special Info
CSF or plasma is unacceptable. Hemolyzed or severely lipemic specimens will be rejected.
Clinical Info
This test is used to check and monitor the presence of anti-John Cunningham virus (JCV) antibodies which is a key factor in evaluating the risk of progressive multifocal leukoencephalopathy (PML) associated with natilizumab therapy.